Funding Opportunities: NIH Acute to Chronic Pain Signatures

From NIH Staff (A2CPS):

I am contacting you on behalf of the NIH for the launch of a NIH Common Fund program: Acute to Chronic Pain Signatures. We are reaching out to those with possible interest in the series of funding opportunities that we have recently released. If you would be willing to distribute information about these opportunities to your community, we would appreciate it.

The Common Fund’s Acute to Chronic Pain Signatures program seeks to identify candidate biomarkers and combine them into biosignatures predictive of the susceptibility or resilience to the development of chronic pain. Ultimately, the program aims to develop a database of pain-related biomarkers that can inform subsequent pain research. These biomarkers will accelerate therapy development and guide pain prevention strategies.

Five opportunities for this program are now available:

Multisite Clinical Center Common Fund Acute to Chronic Pain Signatures Program: Acute Peri-operative Pain (UM1) Clinical Trials Optional
Multisite Clinical Center Common Fund Acute to Chronic Pain Signatures Program: Acute Pain from Musculoskeletal Trauma (UM1) Clinical Trials Optional
Clinical Coordination Center for Common Fund Acute to Chronic Pain Signatures (A2CPS) Program (U24) Clinical Trials Optional
Omics Data Generation Centers (ODGCs) for Common Fund Acute to Chronic Pain Signatures Program (U54) Clinical Trial Optional
Data Integration and Resource Center (DIRC) for Common Fund Acute to Chronic Pain Signatures Program (U54) Clinical Trial Optional

For those who are interested, letters of intent are due September 24, 2018 and applications are due October 24, 2018. An informational webinar will be held on September 6th, 2018 from 2-4 PM, EST.

Join us via WebEx using this link:
Call-in toll number (US/Canada): 1-650-479-3208
Event number: 624 155 354
Event password: PainSig

For additional information, please visit https://commonfund.nih.gov/pain, or contact

Linda L. Porter, Ph.D. (RFA-RM-18-033, RFA-RM-18-034, RFA-RM-18-035)
National Institute on Neurological Disorders and Stroke (NINDS)
Telephone: 301-435-7572
Email: porterl@ninds.nih.gov

John Satterlee, Ph.D. (RFA-RM-18-031, RFA-RM-18-032)
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-1020
Email: satterleej@nida.nih.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this:
search previous next tag category expand menu location phone mail time cart zoom edit close